Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Stella Capriglione, Silvia Latella, Giovanna De Felice, Maurizio Filippini, Carla Ettore, Giuseppe Ettore, Miriam Farinelli & Ferdinando Antonio Gulino. (2022) First trimester screening for aneuploidy: may combined test and fetal DNA work together?. The Journal of Maternal-Fetal & Neonatal Medicine 35:22, pages 4258-4262.
Read now
Read now
Ruofan Yao, Stephen A. Contag, Katherine R. Goetzinger, Sarah D. Crimmins, Jerome N. Kopelman, Sifa Turan & Ozhan M. Turan. (2020) The role of fetal growth restriction in the association between Down syndrome and perinatal mortality. The Journal of Maternal-Fetal & Neonatal Medicine 33:6, pages 952-960.
Read now
Read now
Vedran Stefanovic. (2019) The importance of pre- and post-test counseling for prenatal cell-free DNA screening for common fetal aneuploidies. Expert Review of Molecular Diagnostics 19:3, pages 201-215.
Read now
Read now
Articles from other publishers (29)
Maryam Ghiasi, Christine Armour, Mark Walker, Nicole Shaver, Alexandria Bennett & Julian Little. (2023) Issues associated with possible implementation of Non‐Invasive Prenatal Testing (NIPT) in first‐tier screening: A rapid scoping review. Prenatal Diagnosis 43:1, pages 62-71.
Crossref
Crossref
Elisa Garcia, Lidewij Henneman, Janneke T. Gitsels-van der Wal, Linda Martin, Isabel Koopmanschap, Mireille N. Bekker & Danielle R. M. Timmermans. (2021) Non-invasive prenatal testing (NIPT) and pregnant women’s views on good motherhood: a qualitative study. European Journal of Human Genetics 30:6, pages 669-675.
Crossref
Crossref
Howard Cuckle, Seppo Heinonen, Anna-Kaisa Anttonen & Vedran Stefanovic. (2022) Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies. Journal of Perinatal Medicine 50:3, pages 233-243.
Crossref
Crossref
Yue Hu, Wen Liu, Guoping He, Jingjing Xu, Yaqin Peng & Jing Wang. (2022) Clinical utility of expanded NIPT for chromosomal abnormalities and etiology analysis of cytogenetic discrepancies cases. Journal of Assisted Reproduction and Genetics 39:1, pages 267-279.
Crossref
Crossref
Marsha Michie & Megan Allyse. 2022. Born Well: Prenatal Genetics and the Future of Having Children. Born Well: Prenatal Genetics and the Future of Having Children
105
122
.
Taryn A. G. Quinlan, Brock Schroeder, Sue Kwon, Jane F. Barlow, Michael S. Sherman, Heather D. Anderson, Garth Wright & R. Brett McQueen. (2021) Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement. PharmacoEconomics - Open 5:3, pages 449-458.
Crossref
Crossref
L. Nshimyumukiza, J. A. Beaumont, F. Rousseau & D. Reinharz. (2020) Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
S. Hancock, R. Ben‐Shachar, C. Adusei, C. B. Oyolu, E. A. Evans, H. P. Kang, C. Haverty & D. Muzzey. (2020) Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate. Ultrasound in Obstetrics & Gynecology 56:3, pages 422-430.
Crossref
Crossref
Rocío Cabra-Rodríguez, Guadalupe Bueno Rodríguez, Cristina Santos Rosa, Miguel Ángel Castaño López, Sonia Delgado Muñoz & Antonio León Justel. (2020) Assessment of a change of protocol of prenatal screening by inclusion of non-invasive prenatal diagnosis. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 1:2.
Crossref
Crossref
Rocío Cabra-Rodríguez, Guadalupe Bueno Rodríguez, Cristina Santos Rosa, Miguel Ángel Castaño López, Sonia Delgado Muñoz & Antonio León-Justel. (2020) Valoración de un cambio de protocolo del cribado prenatal mediante la inclusión del diagnóstico prenatal no invasivo. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 1:2.
Crossref
Crossref
Alexandra Benachi, Jessica Caffrey, Pavel Calda, Elena Carreras, Jacques C. Jani, Mark D. Kilby, Hanns-Georg Klein, Giuseppe Rizzo & Yuval Yaron. (2020) Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers. European Journal of Medical Genetics 63:1, pages 103616.
Crossref
Crossref
Maeve K. Hopkins, Lorraine Dugoff, Celeste Durnwald, Laura J. Havrilesky & Sarah Dotters‐Katz. (2019) Cell‐free DNA for Down syndrome screening in obese women: Is it a cost‐effective strategy?. Prenatal Diagnosis 40:2, pages 173-178.
Crossref
Crossref
Nikita M. John, Stuart J. Wright, Sean P. Gavan & Caroline M. Vass. (2019) The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. The European Journal of Health Economics 20:8, pages 1123-1131.
Crossref
Crossref
A. Le Bras, L. J. Salomon, L. Bussières, V. Malan, C. Elie, H. Mahallati, Y. Ville, M. Vekemans & I. Durand‐Zaleski. (2019) Cost‐effectiveness of five prenatal screening strategies for trisomies and other unbalanced chromosomal abnormalities: model‐based analysis. Ultrasound in Obstetrics & Gynecology 54:5, pages 596-603.
Crossref
Crossref
Carrie Guy, Farnoosh Haji‐Sheikhi, Charles M. Rowland, Ben Anderson, Renius Owen, Felicitas L. Lacbawan & Damian P. Alagia. (2019) Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory. Molecular Genetics & Genomic Medicine 7:3, pages e545.
Crossref
Crossref
Yan Xu, Yan Wei, Jian Ming, Na Li, Ningze Xu, Raymond W. Pong & Yingyao Chen. (2019) Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China. International Journal of Technology Assessment in Health Care 35:03, pages 237-242.
Crossref
Crossref
So Yeon Kim, Seung Mi Lee, Jong Kwan Jun, You Jung Han, Min Hyoung Kim, Jae-Yoon Shim, Mi-Young Lee, Soo-young Oh, JoonHo Lee, Soo Hyun Kim, Dong Hyun Cha, Geum Joon Cho, Han-Sung Kwon, Byoung Jae Kim, Mi Hye Park, Hee Young Cho, Hyun Sun Ko, Jeonghoon Ahn & Hyun Mee Ryu. (2018) Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing. BMC Pregnancy and Childbirth 18:1.
Crossref
Crossref
Kathryn A. Phillips, Patricia A. Deverka, Deborah A. Marshall, Sarah Wordsworth, Dean A. Regier, Kurt D. Christensen & James Buchanan. (2018) Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. Value in Health 21:9, pages 1033-1042.
Crossref
Crossref
Lidia García-Pérez, Renata Linertová, Margarita Álvarez-de-la-Rosa, Juan Carlos Bayón, Iñaki Imaz-Iglesia, Jorge Ferrer-Rodríguez & Pedro Serrano-Aguilar. (2017) Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review. The European Journal of Health Economics 19:7, pages 979-991.
Crossref
Crossref
Teresa N. Sparks & Aaron B. Caughey. (2018) How should costs and cost-effectiveness be considered in prenatal genetic testing?. Seminars in Perinatology 42:5, pages 275-282.
Crossref
Crossref
L. Nshimyumukiza, S. Menon, H. Hina, F. Rousseau & D. Reinharz. (2018) Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations. Clinical Genetics 94:1, pages 3-21.
Crossref
Crossref
Mónica Macías, Estibaliz Alegre, Angel Díaz-Lagares, Ana Patiño, Jose L. Pérez-Gracia, Miguel Sanmamed, Rafael López-López, Nerea Varo & Alvaro González. 2018.
73
119
.
Stephen Morris, Caroline S. Clarke & Emma Hudson. 2018. Noninvasive Prenatal Testing (NIPT). Noninvasive Prenatal Testing (NIPT)
269
285
.
Louisa G. Gordon, Catherine A. Hyland, Jonathan A. Hyett, Helen O'Brien, Glenda Millard, Robert L. Flower & Glenn J. Gardener. (2017)
Noninvasive fetal
RHD
genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis
. Prenatal Diagnosis 37:12, pages 1245-1253.
Crossref
Crossref
Blake Murdoch, Vardit Ravitsky, Ubaka Ogbogu, Sarah Ali-Khan, Gabrielle Bertier, Stanislav Birko, Tania Bubela, Jeremy De Beer, Charles Dupras, Meika Ellis, Palmira Granados Moreno, Yann Joly, Kalina Kamenova, Zubin Master, Alessandro Marcon, Mike Paulden, François Rousseau & Timothy Caulfield. (2017) Non-invasive Prenatal Testing and the Unveiling of an Impaired Translation Process. Journal of Obstetrics and Gynaecology Canada 39:1, pages 10-17.
Crossref
Crossref
Emily Suskin, Laura Hercher, Kathleen Erskine Aaron & Komal Bajaj. (2016) The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice. Journal of Genetic Counseling 25:5, pages 1032-1043.
Crossref
Crossref
Talitha I. Verhoef, Melissa Hill, Suzanne Drury, Sarah Mason, Lucy Jenkins, Stephen Morris & Lyn S. Chitty. (2016) Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways. Prenatal Diagnosis 36:7, pages 636-642.
Crossref
Crossref
Rachel G. Sinkey & Anthony O. Odibo. (2016) Cost-Effectiveness of Old and New Technologies for Aneuploidy Screening. Clinics in Laboratory Medicine 36:2, pages 237-248.
Crossref
Crossref
Gautam N. Allahbadia. (2015) Has Noninvasive Prenatal Testing (NIPT) Come of Age?. The Journal of Obstetrics and Gynecology of India 65:3, pages 141-145.
Crossref
Crossref